4//SEC Filing
Horizon Pharma plc 4
Accession 0001209191-16-128018
CIK 0001492426operating
Filed
Jun 14, 8:00 PM ET
Accepted
Jun 15, 5:19 PM ET
Size
5.8 KB
Accession
0001209191-16-128018
Insider Transaction Report
Form 4
Nohria Virinder
Director
Transactions
- Sale
Ordinary Shares
2016-06-15$17.69/sh−25,000$442,280→ 189,836 total
Holdings
- 5,258(indirect: By Trust)
Ordinary Shares
Footnotes (1)
- [F1]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.65 to $17.77 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Documents
Issuer
Horizon Pharma plc
CIK 0001492426
Entity typeoperating
IncorporatedIreland
Related Parties
1- filerCIK 0001492426
Filing Metadata
- Form type
- 4
- Filed
- Jun 14, 8:00 PM ET
- Accepted
- Jun 15, 5:19 PM ET
- Size
- 5.8 KB